Malaysian Agency Consults On Medical Device Recalls
This article was originally published in SRA
The Malaysian Medical Device Authority is inviting stakeholder feedback on a new draft guideline that explains the processes that medical device companies should put in place to initiate a voluntary product recall or to deal with a recall ordered by the regulator1,2.
You may also be interested in...
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.